Shanliang X. Zhong
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Heterogeneity characterization and therapeutic marker discovery of endometrial carcinoma using GeoMXT™ digital spatial profiling.
Journal: Journal of translational medicine
Published: January 06, 2026
tRF-29-86J8WPMN1EJ3: a tRNA-derived small RNA promoting esophageal cancer progression.
Journal: Translational cancer research
Published: July 03, 2025
Prognostic utility of systemic immune-inflammation markers in locally advanced cervical cancer undergoing radical radiotherapy.
Journal: The oncologist
Published: May 19, 2025
Single-cell RNA sequencing reveals altered immune and stromal landscape in primary and liver metastasis of gastric cancer.
Journal: Biochemistry and biophysics reports
Published: April 11, 2025
Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer.
Journal: Translational cancer research
Published: February 03, 2024
tRF-20-S998LO9D inhibits endometrial carcinoma by upregulating SESN2.
Journal: Epigenomics
Published: February 21, 2023
Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma.
Journal: Frontiers in immunology
Published: January 16, 2023
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Journal: Frontiers in immunology
Published: September 29, 2022
CXCL12, a potential modulator of tumor immune microenvironment (TIME) of bladder cancer: From a comprehensive analysis of TCGA database.
Journal: Frontiers in oncology
Published: August 30, 2022
PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.
Journal: Biochemical genetics
Published: June 07, 2022
Last Updated: 09/26/2026